Gill, alongside teammate Dean Hewitt, secured the championship by defeating Sweden with a final score of 8-4. Their win marked not just a sporting achievement but also a moment of national pride amid turmoil. The victory represents a significant milestone for Australian curling, further amplified by the backdrop of social strife.

The atmosphere in Alice Springs was tense. Community members were mourning the loss of five-year-old Kumanjayi Little Baby, whose body was discovered after an extensive search. In response to this tragedy, local residents engaged in community action, leading to the arrest of Jefferson Lewis, who is suspected in her murder. As activist Robin Granites stated, “This man has been caught, thanks to community action, and we must now let justice take its course while we take the time to mourn.”

This situation underscores ongoing issues within Australia regarding violence and community safety—issues that have long plagued Indigenous Australians. With only 3.8% of the population being Indigenous, their voices often go unheard amid broader societal challenges.

This duality of celebration and mourning reflects deeper societal struggles. While Australia rejoices in its curling achievement, it simultaneously grapples with pressing public health concerns, including the elimination of trachoma as a public health problem—a condition that has historically affected Indigenous communities disproportionately.

Key facts:

• Australia became the 30th country to eliminate trachoma as a public health issue.
• Trachoma is one of the leading infectious causes of blindness worldwide.
• The elimination reflects decades of sustained commitment and strong partnerships focused on health equity.
• 400 people clashed with emergency services during protests related to Kumanjayi’s death.
• The community has struggled for decades to reconcile with its Indigenous population.

Dr Tedros Adhanom Ghebreyesus commented on this public health achievement, stating, “This success reflects sustained commitment, strong partnerships, and a focus on reaching populations most affected by health inequities.” His remarks highlight that progress can occur even when faced with adversity.

Currently, about 20% of the city’s water management infrastructure holds a ‘high criticality’ rating. This alarming statistic signals potential major impacts on service delivery if immediate action is not taken.

Officials like Christine Fréchette and Gilles Bélanger have pointed out that 52% of stormwater pumping stations are in poor condition. Moreover, 29% of wastewater treatment plants and related facilities also fall into this category.

The situation has led to an average of 3,645 annual requests related to backups and overflows at wastewater treatment plants. This raises serious concerns about the reliability of these essential services.

The funding gap is staggering. The city needs an average of $1.52 billion annually just to maintain its current systems—almost double the existing budget for water management.

Dr. Daniel Viens warns that delays in addressing these issues could lead to severe public health consequences: “Il y aura des traitements de chimiothérapie qui vont être retardés.” Such statements underline the urgency of the situation.

Alan de Sousa reassures residents, stating, “On ne restera pas les bras croisés.” This sentiment reflects a growing commitment among officials to tackle these challenges head-on.

Sylvain Ouellet raises an important question: “L’argent, il va le prendre où ?” Funding sources remain unclear as discussions continue regarding how to finance these necessary upgrades.

The goal is to reduce the maintenance deficit from 8% to 5% within ten years—a target that seems ambitious given the current financial landscape.

This crisis has been brewing for years, with various reports highlighting the deteriorating state of Montreal’s infrastructure. Yet, no definitive timeline has been shared for when these investments will materialize or how they will be allocated.

The path forward remains uncertain but urgent. As officials scramble to secure funding, one thing is clear: without decisive action, Montreal risks facing significant disruptions in its vital water services.

The post Le journal de montréal: Montreal Water Management Crisis: A Call for Infrastructure Investment appeared first on News Canada.

Then came the decisive moment: Donald Trump announced Erica Schwartz’s nomination to lead the CDC on Truth Social. This was no ordinary appointment. Schwartz, a rear admiral in the US Coast Guard, previously served as deputy surgeon general from 2019 to 2021. Her credentials include a medical degree from Brown University and a law degree from the University of Maryland.

The immediate effects of this nomination are noteworthy. Schwartz is expected to bring a fresh perspective to an agency often criticized for its handling of public health crises. Yet, she must first secure Senate confirmation—a hurdle that could prove challenging given the political landscape.

In contrast to her predecessor, Schwartz’s approach may differ significantly. Monarez’s abrupt removal highlighted internal conflicts within the CDC regarding vaccine messaging—a contentious issue that continues to polarize public opinion. Kayla Hancock voiced concerns about ensuring independence in leadership, emphasizing that “the next CDC director must be free and independent.”

Experts are weighing in on what this shift means for public health policy moving forward. Some believe Schwartz could help restore confidence in the CDC’s scientific integrity—something that has been sorely tested in recent years. Trump’s assertion that Schwartz represents “the GOLD STANDARD OF SCIENCE” reflects an urgent desire for stability.

However, doubts linger about whether her nomination will truly signify a change or merely continue existing tensions within the agency. Details remain unconfirmed about how Schwartz plans to navigate these challenges if confirmed.

The stakes are high. With ongoing debates surrounding vaccination and public health measures, her leadership will be scrutinized closely. Will she advocate for robust public health initiatives? Or will she find herself caught in the crossfire of political agendas?

This moment could very well shape the future of how Americans view their health authorities. As we await Senate confirmation, one thing is clear: Erica Schwartz’s nomination is more than just an appointment—it’s a potential turning point for the CDC.

The post Erica Schwartz: A New Era for the CDC? appeared first on News Canada.

The infected individual, who is adequately vaccinated against measles, visited several large retail stores, including Dollarama, Costco, Winners, and Maxi, on April 6 and 8. Additionally, they were present at the Hôpital de l’Enfant-Jésus on April 7, 8, and 9. This pattern of activity during the contagious period raises significant concerns about potential exposure to the virus among the general population.

Symptoms of measles typically begin with a fever, cough, runny nose, and red, watery eyes, followed by a rash that can appear up to 21 days after exposure. Given the three-hour window of exposure following the presence of the infected person, anyone who visited these locations during the specified times is considered a contact of a confirmed case. Health officials are urging these individuals to monitor for symptoms until the end of April.

“Les personnes qui se trouvaient dans les endroits identifiés durant les dates et heures indiquées sont considérées comme des contacts d’un cas confirmé de rougeole,” stated the Direction de la santé publique, emphasizing the importance of vigilance among those who may have been exposed. The highly contagious nature of measles, combined with the fact that vaccination significantly reduces the risk of developing symptoms, highlights the critical role of immunization in public health.

Despite the vaccination status of the infected individual, the ongoing epidemiological investigation aims to determine the exact location of the disease acquisition. As it stands, the total number of cases may increase as health authorities continue to monitor the situation closely. The public is reminded that measles can spread rapidly, particularly in settings where individuals congregate.

Dr. Sara Jeanne Pelletier noted, “Au moins, le vaccin protège contre les complications et aussi on peut s’attendre à une contagiosité diminuée.” This statement underscores the importance of vaccination not only for individual protection but also for community health. The current outbreak serves as a stark reminder of the vulnerabilities that can arise when vaccination rates decline or when individuals remain unvaccinated.

As the investigation unfolds, health officials are working diligently to trace contacts and provide guidance to those who may have been exposed. People who frequented the identified locations are advised to keep a close watch for any symptoms that may arise. Details remain unconfirmed regarding the exact source of the second case, but the urgency of the situation cannot be overstated.

In summary, the emergence of a second measles case in Quebec amidst an ongoing outbreak raises significant public health concerns. With the potential for further infections, the community must remain vigilant and proactive in monitoring symptoms and adhering to health guidelines. The situation is evolving, and continued updates from health authorities will be crucial in managing this outbreak effectively.

The post Rougeole: Measles Outbreak in Quebec: Second Case Confirmed appeared first on News Canada.

Canada is grappling with a troubling rise in cases of invasive meningococcal disease (IMD), a dangerous bacterial infection caused by the Neisseria meningitidis bacterium. Recent reports indicate that the number of cases has surged to nearly 100 in 2023, a stark increase from 74 cases in 2022 and just 48 in 2021. This alarming trend has prompted health officials to issue warnings about the potential risks, particularly for infants and young adults who are most vulnerable to severe outcomes.

In Manitoba, the situation is particularly dire, with the province experiencing an outbreak of the meningococcal W strain. Over the past three years, Manitoba has reported above-average case counts, culminating in a staggering fivefold increase in annual cases compared to previous years. In 2025 alone, there were 155 reported cases, with four fatalities among 23 cases, raising the death rate to a concerning 14 percent.

Saskatchewan has also seen a notable uptick, with annual IMD cases rising from just four in 2024 to 17 in 2025. This spike in cases across provinces highlights a broader public health challenge, as vaccination coverage for the meningococcal C vaccine has declined significantly from over 90 percent in 2019 to below 84 percent by 2024.

Public health officials stress that meningococcal disease spreads through close contact or respiratory secretions, making awareness and preventive measures crucial. Dr. Cristin Muecke emphasized the seriousness of the disease, stating, “That’s a very significant consequence and very serious disease at such a young age.” Meanwhile, Dr. Joanne Langley expressed concern over the declining vaccination rates, noting, “It’s very worrisome that our coverage rates have changed.”

The rise in IMD cases is particularly perplexing, as the reasons behind this increase remain unclear. Details remain unconfirmed regarding the specific epidemiology of the W strain in Manitoba, leaving health experts to investigate further. Jason Fryza, a resident affected by the outbreak, remarked, “Everything happened so fast,” reflecting the urgency of the situation.

As health officials continue to monitor the outbreak, they are urging communities to remain vigilant and consider vaccination as a critical defense against this dangerous bacterial infection. The situation serves as a stark reminder of the importance of public health measures and the need for ongoing education about vaccine-preventable diseases.

The post Dangerous bacterial infection in canada: Canada Faces Surge in Dangerous Bacterial Infection Cases appeared first on News Canada.

In recent developments, a significant food safety issue has emerged in Canada as Gorgonzola cheese has been recalled due to contamination with Listeria monocytogenes. This recall affects 200-gram packages of Gorgonzola D.O.P. dolce from the brand Auricchio, primarily distributed in Ontario and Quebec.

The Canadian Food Inspection Agency (CFIA) discovered the contamination during routine testing, prompting the recall. The affected cheese has a best-before date of August 5, 2026, which raises questions about the safety of products that may still be on store shelves.

While there have been no reported illnesses linked to this specific product, the potential health risks associated with Listeria are significant. Listeria can cause serious illness, particularly in vulnerable populations such as pregnant women, the elderly, young children, and individuals with compromised immune systems.

Symptoms of Listeria infection can manifest as vomiting, nausea, persistent fever, muscle aches, severe headache, and neck stiffness. Notably, food contaminated with Listeria may not exhibit any visible signs of spoilage, making it particularly insidious.

Consumers are advised to monitor themselves for symptoms in the weeks following exposure, as it can take up to 70 days for symptoms to develop. The CFIA has emphasized the importance of vigilance during this period.

The recall was initiated by Auricchio, reflecting a proactive approach to consumer safety. However, the lack of reported illnesses does provide some reassurance, though the situation remains a cause for concern.

As the recall unfolds, it serves as a reminder of the potential dangers lurking in food products that may appear safe. The CFIA continues to investigate the source of the contamination and ensure that affected products are removed from the market.

This incident underscores the critical role of food safety regulations and the importance of consumer awareness in preventing foodborne illnesses. The ongoing monitoring and testing by agencies like the CFIA are vital in maintaining public health standards.

As more information becomes available, stakeholders in the food industry and consumers alike will be watching closely to understand the full implications of this recall.

The post Canada cheese recall listeria: Canada Cheese Recall: Listeria Contamination Sparks Concern appeared first on News Canada.

Tuberculosis is making a troubling comeback in Canada, raising the question: why is this infectious disease, once on the decline, now resurging? The answer lies in a combination of factors, including increased population mobility and inadequate public health measures, as highlighted by Simon Grandjean Lapierre, a clinical professor at the University de Montréal and a researcher at the CHUM Research Centre.

Since the COVID-19 pandemic, Canada has witnessed a significant increase in tuberculosis cases, particularly on the Island of Montreal. “We’ve seen a significant increase in cases on the Island of Montreal since 2023,” Lapierre stated, emphasizing the urgency of the situation.

Historically, Canada experienced a steady decrease in tuberculosis incidence starting in the 1950s, but recent trends indicate a worrying reversal. The CHUM diagnoses between 20 and 40 tuberculosis cases annually, a number that has been rising in recent years.

Lapierre leads a translational research program focused on tuberculosis control not only in Canada but also in Madagascar, where his team is involved in a three-year study with 46,000 participants. This international perspective allows for a broader understanding of the disease’s dynamics and the factors contributing to its resurgence.

Key drivers of the recent increase include precarious living conditions and inadequate screening processes, which have left many vulnerable to infection. “It’s what we call a ‘re-emerging’ disease,” Lapierre explained, highlighting the critical need for renewed public health actions to combat this threat.

In response to the growing challenge, Lapierre’s team is developing new diagnostic tools aimed at identifying antibiotic resistance in tuberculosis bacteria. This innovation is crucial, as antibiotic-resistant strains of tuberculosis pose a significant risk to public health.

As the situation evolves, the implications for public health in Canada are profound. Lapierre warns, “If we don’t take appropriate public health actions, everyone remains at risk.” The resurgence of tuberculosis serves as a stark reminder of the vulnerabilities within the healthcare system, particularly in the wake of a global pandemic.

Details remain unconfirmed about the exact trajectory of tuberculosis cases in the coming years, but the need for proactive measures is clear. The collaboration between researchers like Lapierre and public health officials will be essential in addressing this pressing health crisis.

The post Jean lapierre: The Resurgence of Tuberculosis: What Does Have to Say? appeared first on News Canada.

The emergence of the cicada COVID variant, officially designated BA.3.2, is causing a significant rise in cases across the United States and globally. This variant, first detected in a traveler arriving in the U.S. in June 2025, has raised alarms due to its high mutation rate, boasting between 70 and 75 mutations. As of March 2026, BA.3.2 accounts for approximately 30% of COVID-19 sequences in Germany and several Northern European countries.

Since its first U.S. diagnosis in January 2026, BA.3.2 has spread to at least 25 states, with detection in 3.7% of wastewater samples as of mid-March. The World Health Organization classified BA.3.2 as a ‘variant under monitoring’ in December 2025, indicating the global health community’s concern regarding its potential impact.

Experts emphasize the importance of monitoring BA.3.2 to understand its capability to evade immunity from previous infections or vaccinations. The CDC noted, “Monitoring the spread of BA.3.2 provides valuable information about the potential for this new SARS-CoV-2 lineage to evade immunity from a previous infection or vaccination.” This highlights the ongoing challenges in managing the pandemic as new variants emerge.

Despite the alarming statistics, some experts suggest that the variant has not yet led to a significant increase in severe disease. Andrew Pekosz, Ph.D., remarked, “It looks scary on paper, but it hasn’t really made a big impact in terms of disease in most places yet.” This sentiment underscores the complexity of assessing the variant’s actual threat level.

However, the situation is precarious. Dr. Robert H. Hopkins, Jr. warned that low vaccination rates and insufficient public health measures leave the population vulnerable to a potential surge. Current COVID vaccines are expected to continue providing protection against severe disease from BA.3.2, but the effectiveness of these vaccines against the variant is still under investigation.

As of now, BA.3.2 has been reported in at least 23 countries, with 132 sites where it was detected in wastewater samples. The variant’s rapid spread raises questions about its future trajectory and the public health response required to mitigate its impact.

Details remain unconfirmed regarding the potential for BA.3.2 to cause a surge in the U.S. and the ongoing studies into vaccine effectiveness against this variant. The coming weeks will be crucial in determining how this new variant will shape the landscape of the ongoing pandemic.

The post Cicada COVID Variant: Rising Threat Amidst Uncertainty appeared first on News Canada.

On March 31, 2026, a hybrid colloquium titled “Living with the Climate Change Consequences: Reshaping the Social Contract” will take place at the OIA Boardroom and virtually via Zoom. This event is part of the MaGIC initiative and specifically the FORESEE research program, which has received a significant funding of 9 million euros over seven years.

The colloquium aims to connect researchers who are studying the multifaceted consequences of climate change, particularly its impact on health systems. The event is open to all faculty, researchers, postdocs, and PhD students at McMaster University, fostering a collaborative environment for discussing pressing issues.

As climate change increasingly affects health systems globally, the colloquium will feature discussions on how these systems are being redefined. Increasing temperatures and extended droughts are altering disease patterns in Africa, exposing the fragility of health systems that were designed for stability.

Professor Anthony Ngugi, a speaker at the event, emphasizes that “climate change adaptation is not a nice-to-have feature of health systems but an essential capability of health security.” This statement underscores the urgent need for health systems to integrate climate adaptation into their planning and investment decisions.

In light of the upcoming World Health Summit regional meeting scheduled for April 27-29, the colloquium serves as a timely platform to address these critical issues. The discussions will highlight how Africa is developing health models that are resilient and responsive to climate risks.

Marina Johnson-Zafiris will also present her dissertation work on technology and environmental justice, further enriching the dialogue around the intersection of climate change and health.

As the colloquium approaches, the urgency of the situation becomes increasingly clear. Climate change is not merely an environmental or economic issue; it is now recognized as a critical health crisis that requires immediate action.

Professor Ngugi’s assertion that “our resilience in this age of disruption will be defined not by what we promise for tomorrow, but by what we do today” serves as a rallying cry for all stakeholders involved in health and climate policy.

The event is poised to generate significant discourse on how to reshape the social contract in light of climate change, ensuring that health systems are equipped to handle the challenges ahead.

Details remain unconfirmed regarding the specific outcomes of the colloquium, but the anticipation surrounding it reflects a growing recognition of the need for urgent action in the face of climate change.

The post Climate change: Colloquium on : A Call to Action for Health Systems appeared first on News Canada.

The outbreak, which has affected the Canterbury area, has prompted health authorities to contact over 30,000 individuals in the community. The NHS has initiated a targeted vaccination campaign for students living in halls of residence, aiming to curb the spread of meningococcal group B disease. This strain of meningitis can develop rapidly and is known for its severe consequences, with a fatality rate of 70-80% when the infection enters the bloodstream.

Vaccination is currently the best form of protection, as emphasized by a spokesperson for the University of Kent. However, the situation is complicated by the fact that every student currently enrolled was born before July 2015, missing the cut-off for the Bexsero vaccine, which was added to the UK’s national immunization schedule only for babies. This gap in vaccination coverage has left a vulnerable population at risk.

Data indicates a concerning trend: a study found that the proportion of students carrying meningococcal bacteria surged from less than 7% to over 23% within just four days of starting university. This rapid increase highlights the link between university life and meningococcal risk, a connection that has been established for decades. In the United States, first-year undergraduate students are almost 12 times more likely to contract meningococcal B disease compared to their non-student peers.

Despite the availability of the Bexsero vaccine since 2013, the NHS has not offered it to students born before July 2015, creating a significant gap in protection. As a result, private vaccination bookings have surged to 65 times their normal levels following the outbreak, raising concerns about access to care. A public health expert at the London School of Hygiene and Tropical Medicine noted that this situation creates inequities, as the availability of private vaccination depends on individuals’ ability to pay.

Looking ahead, Health Secretary Wes Streeting plans to ask the Joint Committee on Vaccination and Immunisation (JCVI) to re-examine eligibility for meningitis vaccines in light of the outbreak. The economic rationale for limiting the vaccine program to infants has been increasingly questioned since 2015, as highlighted by Philip Broadbent. The first cohort of babies vaccinated in 2015 will not reach university age until 2033, leaving a significant gap in vaccination coverage for current students.

As health authorities continue to respond to this outbreak, the urgency of addressing vaccination gaps becomes clear. The tragic loss of life and the rising number of cases serve as a stark reminder of the importance of timely vaccination and public health initiatives. Details remain unconfirmed regarding the full extent of the outbreak and its long-term implications, but the need for immediate action is evident.

The post Meningococcal Meningitis Outbreak: A Crisis at the University of Kent appeared first on News Canada.